Response to Letter of Li et al.: How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?
De Rosa, Roberta
Response to Letter of Li et al.: How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing? [electronic resource] - International journal of cardiology 11 2018 - 30 p. digital
Publication Type: Letter; Comment
1874-1754
10.1016/j.ijcard.2018.06.048 doi
Acute Coronary Syndrome
Aspirin
Blood Platelets
Drug Therapy, Combination
Humans
Pharmacogenomic Testing
Platelet Aggregation Inhibitors
Platelet Function Tests
Prasugrel Hydrochloride
Ticlopidine
Response to Letter of Li et al.: How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing? [electronic resource] - International journal of cardiology 11 2018 - 30 p. digital
Publication Type: Letter; Comment
1874-1754
10.1016/j.ijcard.2018.06.048 doi
Acute Coronary Syndrome
Aspirin
Blood Platelets
Drug Therapy, Combination
Humans
Pharmacogenomic Testing
Platelet Aggregation Inhibitors
Platelet Function Tests
Prasugrel Hydrochloride
Ticlopidine